Telephone Versus In-person Post-test Cancer Genetic Counseling
GEO-STAR
Cancer Genetic Counseling: Telephone Versus Standard In-person Delivery. A Randomized Trial (GEO-STAR)
1 other identifier
interventional
724
1 country
1
Brief Summary
The purpose of the GEO-STAR randomized non-inferiority trial is to compare the outcome of post-test telephone cancer genetic counseling with standard in-person cancer genetic counseling. We hypothesize that telephone counseling is non-inferior by outcome if compared to standard in-person counseling.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2021
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 15, 2021
CompletedFirst Posted
Study publicly available on registry
February 18, 2021
CompletedStudy Start
First participant enrolled
May 15, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2025
CompletedJuly 28, 2021
July 1, 2021
4 years
February 15, 2021
July 22, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
"Multidimensional Impact of Cancer Risk Assessment" questionnaire
Impact of post-test counseling on patients. The "Multidimensional Impact of Cancer Risk Assessment" questionnaire measures distress, uncertainty and positive experiences associated to cancer genetic testing. A version adapted to the Italian context will be used, where a single item related to insurance has been removed because not applicable to the Italian Health System. The resulting possible scores range from 0 to 100. Higher scores indicate more negative impacts of cancer risk assessment.
Seven days after the post-test genetic counseling session
"Patient perceptions of the genetic counseling questionnaire"
Impact of post-test counseling on patients. The range of scores is from 8 to 31. Higher scores indicate positive perception of the genetic counseling session.
Seven days after the post-test genetic counseling session
"Genetic Counselor process Questionnaire"
Professionals perceptions measured by the Genetic Counselor process Questionnaire completed by professionals who provided the post-test genetic counseling. The range of scores is from 4 to 20. Higher scores indicate positive perception of the genetic counselor.
Immediately after the post-test genetic counseling session
Secondary Outcomes (2)
Influence of sociodemographic and medical history on genetic counseling outcomes
Data collection during pre-test genetic counseling session
Impact of logistics on genetic counseling preferences
Data collection during the pre-test genetic counseling session
Study Arms (2)
Telephone post-test genetic counseling
EXPERIMENTALPost-test genetic counseling delivered by telephone
In-person post-test genetic counseling
NO INTERVENTIONPost-test genetic counseling delivered in-person
Interventions
Participants enrolled in the experimental arm will receive genetic counseling for test result communication by telephone.
Eligibility Criteria
You may qualify if:
- Patients over 18 years of age inclusive at the time of the study;
- Patients must have undergone an in-person pre-test genetic counseling session;
- Patients must have undertaken cancer genetic testing;
- Patients must be able to speak Italian fluently;
- Patients must have got an email address.
You may not qualify if:
- Patients unable to provide informed consent, for example due to mental incapacity or active psychotic illness.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UO Genetica Medica, IRCCS AOU di Bologna
Bologna, 40138, Italy
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof.
Study Record Dates
First Submitted
February 15, 2021
First Posted
February 18, 2021
Study Start
May 15, 2021
Primary Completion
April 30, 2025
Study Completion
April 30, 2025
Last Updated
July 28, 2021
Record last verified: 2021-07
Data Sharing
- IPD Sharing
- Will not share